APP gene dosage in familial AD and DS has driven hypotheses connecting AD pathogenesis with increased incidence of trisomy 21 (Heston and Mastri, 1977; Potter, 1991; Geller and Potter, 1999). The gene discussed is APP; the disease is Alzheimer disease.